IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: General and other surgery

In 2025 Q1–Q4, the provider or facility offer prevailed in 88.0% of 39,251 determined Federal IDR dispute line items for general and other surgery. The median prevailing offer was 7.64x the QPA (25th–75th percentile 2.00x–27.17x; n = 35,846). The median time to a decision was 33 business days (n = 39,251).

Specialty group built from the CMS free-text specialty field; see the grouping rules.

Determined line items

39,251

2025 Q1–Q4 · 46 split decisions excluded

Provider win rate

88.0%

n = 39,251 · 2025 Q1–Q4

Median payment vs QPA

7.64x

middle half 2.00x–27.17x · n = 35,846 · 2025 Q1–Q4

Median days to decision

33

business days, from dispute initiation · n = 39,251 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q439,25188.0%7.64x2.00x–27.17x35,84633
2024 Q1–Q415,17986.5%9.72x3.33x–21.55x13,69355
2023 Q1–Q42,50479.9%8.27x2.16x–18.59x2,37364
2023 Q1–2025 Q456,93487.3%8.25x2.17x–25.05x51,912not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

By state

State (place of service)Line itemsWin %Median ×QPARatio nMedian days
New Jersey11,05286.4%18.41x10,36133
Oklahoma8,16898.4%2.00x7,94132
New York5,41086.2%20.68x †4,93632
Texas4,06478.6%9.35x2,54531
Colorado3,89086.7%5.22x3,81149
California3,53687.6%36.83x †3,50529
Florida1,30685.2%11.34x1,20229
Maryland65578.2%8.27x47431
Arizona42984.8%25.86x †42528
Nevada17493.7%57.89x †17427
Kansas17093.5%4.23x14940.5
Wisconsin10794.4%5.61x7853
Utah7386.3%2.09x7236
Georgia6066.7%1.00x6034
Connecticut4095.0%5.43x3433
Indiana3597.1%–175

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
99232 Subsequent hospital care with moderate levelof medical decision making, if using2,94085.3%9.23x2,91046
44970 Removal of appendix using an endoscope1,93786.2%24.62x †1,81631
47562 Removal of gallbladder using an endoscope1,73585.6%29.30x †1,62934
99222 Initial hospital care with straightforward or low-level medical decision making,1,05686.1%14.59x1,02639
99233 Subsequent hospital care with moderate levelof medical decision making, if using94883.9%5.99x90437.5
99285 Emergency department visit with high level of medical decision making89089.8%2.30x80532
47563 Removal of gallbladder with X-ray study of bile ducts using an endoscope88386.9%23.70x †81329
99284 Emergency department visit with moderate level of medical decision making77487.7%6.71x73434
99231 Subsequent hospital care with straightforward or low level of medical decision m66386.4%26.09x †65631
99291 Critical care, first 30-74 minutes65089.1%6.36x62541
49650 Repair of groin hernia using an endoscope53387.4%41.75x †51031
43775 Partial removal of stomach for weight loss using an endoscope52289.3%25.03x †49834
99223 Initial hospital care with moderate level of medical decision making, if using t52285.2%9.72x50231
85025 Complete blood cell count (red cells, white blood cell, platelets), automated te51494.2%3.16x46631
80053 Blood test, comprehensive group of blood chemicals41398.1%1.14x39832
99283 Emergency department visit with low level of medical decision making37087.6%11.99x35936
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscop35486.4%7.79x34527
58662 Destruction or removal of ovary or growth of pelvis using an endoscope35082.0%42.73x †30427
43281 Repair of hernia of muscle at esophagus and stomach using an endoscope29584.7%22.54x †28629
99221 Initial hospital care with straightforward or low level of medical decision maki26281.7%14.40x26034
96375 Injection of additional new drug or substance into vein23895.8%1.71x21031.5
64488 Injection of local anesthetic for abdominal wall pain control on both sides usin23388.4%16.29x22428
14301 Repair of wound by transferring skin, 30.1-60.0 sq cm21487.9%13.90x21136
44180 Release of small bowel scar tissue using an endoscope21193.8%24.37x †19434
15734 Creation of muscle graft to trunk21081.4%18.30x20433

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

FAQ

What is the Federal IDR provider win rate for general and other surgery?

In 2025 Q1–Q4, the provider or facility offer was selected in 88.0% of 39,251 determined dispute line items for general and other surgery. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for general and other surgery?

In 2025 Q1–Q4, the median prevailing offer was 7.64x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 2.00x to 27.17x (n = 35,846 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for general and other surgery?

In 2025 Q1–Q4, the median was 33 business days (n = 39,251 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR